Tutorials
Instadose Pharma Corp logo

Instadose Pharma Corp

$ 0.50 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
9.43
Market Cap:
$ 265.97M
Enterprise V:
$ 266.15M
Volume:
100.00
Avg Vol (2M):
163.00
Volume:
100.00
Market Cap $:
265.97M
PE Ratio:
At Loss
Avg Vol (2-Month):
163.00
Enterprise Value $:
266.15M
PB Ratio:
9.43
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Instadose Pharma Corp
NAICS : 325411 SIC : 2834
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Description
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.
Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset 0.78
Debt-to-Equity 0.01
Debt-to-EBITDA -0.2
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 84.16
9-Day RSI 56.27
14-Day RSI 38.87
6-1 Month Momentum % -74.63
12-1 Month Momentum % -59.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.01
Quick Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
ROE % -24.59
ROA % -3.77
ROIC % -3.39
ROC (Joel Greenblatt) % -42.57
ROCE % -24.15

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 9.43
Price-to-Free-Cash-Flow 83.33
Price-to-Operating-Cash-Flow 83.33
EV-to-EBIT -198.47
EV-to-EBITDA -276.95
EV-to-FCF 468.62
Earnings Yield (Greenblatt) % -0.5

Financials

INSD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:INSD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.013
Beta 0
Volatility % 318.22
14-Day RSI 38.87
14-Day ATR ($) 0.074059
20-Day SMA ($) 0.26715
12-1 Month Momentum % -59.4
52-Week Range ($) 0.0003 - 60
Shares Outstanding (Mil) 531.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Instadose Pharma Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More